ORLANDO—Adjuvant chemotherapy was found to extend life in patients with locally advanced bladder cancer in research reported to the 2015 Genitourinary Cancers Symposium. Matt Galsky MD from the Tisch
ORLANDO—Adjuvant chemotherapy was found to extend life in patients with locally advanced bladder cancer in research reported to the 2015 Genitourinary Cancers Symposium. Matt Galsky MD from the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, explained his conclusions—based on data from a population-based study with over 4,000 patients—to Oncology Times reporter Sarah Maxwell.
Abstract Number:
292
Citation:
J Clin Oncol 33, 2015 (suppl 7; abstr 292)
Comparative effectiveness of adjuvant chemotherapy (AC) versus observation in patients with ≥ pT3 and/or pN+ bladder cancer (BCa).
Abstract URL: http://meetinglibrary.asco.org/content/141139-159
Related Episodes
Castration-resistant prostate cancer with bone metastases: long follow up shows radium is safe as well as effective
SAN FRANCISCO—New research has shown the alpha-emitting drug radium 233 to be a “benign” therapy with no major toxicities — while effectively targeting bone metastatic disease and increasi
Enzalutamide in metastatic castration resistant prostate cancer: over 75s benefit too
ORLANDO, FLORIDA—Men over 75 were safely and effectively treated for their metastatic castration-resistant prostate cancer with the androgen receptor inhibitor enzalutamide in the Phase III AFFIRM stu
Low risk localized prostate cancer: no harm from waiting!
ORLANDO, FLORIDA—A decision to delay surgery or radiotherapy for early prostate cancer is in the best interests of most patients according to research presented to the 2013 Genitourinary Cancers Sympo